A History of Indian Medical Literature v2.c30.411

v2.c30.411

427 See on the treatment of pāṇḍuroga: A. Kumar (1994): 280; P.B. Kurup, V. Hariharan and K. Rajagopalan (1975); K. Swayam Prakasam (1991). See on the treatment of pāṇḍuroga in Buddhist literature: K.G. Zysk (1988): 128–129, (1991): 106–107. See on the treatment of kāmalā, hepatitis, and the influence of āyurvedic drugs on the liver: D.S. Antarkar et al. (1980); B.K. Chandan, A.K. Sharma and K.K. Anand (1991); G.N. Chaturvedi and R.H. Singh (1965), (1966); G.N. Chaturvedi et al. (1983); A. Chaube, S.K. Dixit and P. Chaube (1997); M.L. Dwivedi, S.V. Tripathi and H.S. Dwivedi (1984); S.S. Handa, A. Sharma and K.K. Chakraborti (1986); S.V. Kantikar et al. (1976); *V.N. Pandey (1980); V.N. Pandey and G.N. Chaturvedi (1968), (1969), (1970); S.C. Sheth et al. (1960); D.S. Singh et al. (1991); T. Sreerama Murthy et al. (1993); Suresh Kumar et al. (1982); Suresh Kumar, Asha Mishra and G.N. Chaturvedi (1982); D. Umarani et al. (1985); A.B. Vaidya (1982); *A.B. Vaidya et al. (1976); B.J. Vakil et al. (1974). See on the treatment of hepatitis in general and of viral hepatitis in Siddha medicine: G. Ganapathy (1983); R. Thyagarajan (1983). 428 Compare Ca.Ci.16.39cd–43 and Su.U.44.14–15, 16.52–55ab and Su.U.44.30cd–31ab, 16.69 and Su.U.44.21, 16.70–71 and Su.U.44.17, 16.78–79 and Su.U.44.23, 16.93cd–96 and Su.U.44.24, 16.98–102ab and Su.U.44.30cd–31ab. 429 Cf. Su.U.44.12cd. Some Indian physicians regard kala-azar as belonging to halīmaka; see, for example, P. Pāṇḍey (1991). See on kala-azar in India: U. Brahmachari (1946); M.J. Joshi and C.D. Deshpande (1972): 6–7; L.E. Napier and C.R. Das Gupta (1931); L.E. Napier and K.V. Krishnan (1933); H.H. Scott (1992): 548–563; C.A.K. Shanmugham, R.G. Roy and A.V. Ganesan (1977). 430 Cf. Bhela Ci.25.10–11. 431 Cf. A.h.Ci.16.2–4. See for a study of this ghee: L. Sarada Amma and P.K. Narayana Sharma (1982). See on the uses of dāḍima: P.V. Sharma (1996): 188–190. 432 See on the uses of kaṭuka: P.V. Sharma (1996): 69–70. 433 Cf. A.S.Ci.16.21; Cakradatta, pāṇḍuroga 52. 434 Cf. Cakradatta, pāṇḍuroga 53. See on the uses of haridrā: P.V. Sharma (1996): 402–404. 435 This formula forms part of the Cakradatta (pāṇḍuroga 11–12). See on this compound drug: R. Desāī (1980): 271–272; P. Suresh and V.D. Kumari (1994). Cf. Su.Ci.12.11. 436 Cf. Cakradatta, pāṇḍuroga 42–44 (punarnavāmāṇḍūra); Gadanigraha, prayogakhaṇḍa, guṭikādhikāra 282–285ab (punarnavāmāṇḍūra). 437 See on the uses of dhātrī (= āmalakī): P.V. Sharma (1996): 33–39. See on a compound dhātryādiyoga: M. Dwivedi and P.V. Tewari (1991). 438 See on the uses of bījaka = asana: P.V. Sharma (1996): 31–32. 439 Cf. Cakradatta, pāṇḍuroga 49–51. 440 These substances are: ayorajas (16.69, 70, 78, 97, 98, 105, 119), lauharajas (16.82), maṇḍūra (16.72, 74, 76, 85, 103). 441 See on iron preparations in the treatment of pāṇḍuroga: S. Venkataraghavan et al. (1977a). 442 Cakra explains that these three factors are asātmyendriyārthasamyoga, pariṇāma and prajñāparādha. 443 The āmāśaya according to Cakra. 444 Cf. Su.U.50.3–5 (hikkā, śvāsa, kāsa) and 51.3 (śvāsa). 445 Cf. Ca.Ci.17.45 (samprāpti of śvāsa); Su.U.50.6 (samprāpti of hikkā) and 51.4 (samprāpti of śvāsa).